Company Analysis

Armata Pharmaceuticals, Inc. (ARMP)

NYSE: ARMP · Biological Products, (No Diagnostic Substances) · Los Angeles, CA · filing with the SEC since 1996
Grade4.7
◀ Past 6.0● Present 4.6▶ Future 3.9
6 est.

The company now

Armata Pharmaceuticals, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Los Angeles, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported a loss of $174 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.

SI Assistanton ARMP · research, not advice